查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1548075

全球疫苗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2个工作天内

价格

全球疫苗市场需求预计将从2023年的1,274.1亿美元达到2032年近1,591.1亿美元的市场规模，2024-2032年研究期间复合年增长率为2.5%。

疫苗是透过产生针对特定疾病的免疫力来保护人们免受疾病侵害的物质。它含有死亡或弱化的微生物；这些微生物刺激免疫系统产生抗体。大多数疫苗透过注射、鼻腔或口腔注射。根据用于活化或刺激免疫系统的策略，疫苗分为不同类型：灭活疫苗、减毒疫苗、类毒素疫苗、次单位疫苗、实验疫苗、价疫苗、异型疫苗和合併疫苗。有许多疫苗正在开发中，尚未商业化。

市场动态

预计全球根除目标和人口扩张将推动疫苗市场的成长。每年，估计有 200-300 万儿童死亡和 60 万成人死亡透过疫苗接种得到预防。儘管如此，仍有许多疾病每年夺走数百万人的生命，而且目前还没有有效的疫苗，这促使人们对新的和改进的疫苗进行研究和开发。高收入国家是疫苗的主要购买国，占全球疫苗销售量的 82%。然而，疫苗浪费被认为是影响市场收入的一个主要问题。还有一个担忧是，一些国家没有足够的资金购买疫苗，而一些国家由于国家当局运作不善而没有进行疫苗开发所需的资源或授权。这会影响疫苗未来的可行性。为了评估这些影响成长的因素，世卫组织正在采取各种措施，开发一套工具来支持规划和合作伙伴衡量和解决疫苗接种不足问题。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球疫苗市场的各个细分市场进行了包容性评估。疫苗产业的成长和趋势为本研究提供了整体方法。

市场区隔

疫苗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 次单位疫苗（重组疫苗、结合疫苗、类毒素疫苗）
  • 灭活
  • 活衰减
  • mRNA疫苗
  • 病毒载体疫苗

依给药途径

  • 口服
  • 注射用
  • 鼻腔

按疾病适应症

  • 病毒性疾病（肝炎、流感、HPV、MMR、轮状病毒、带状疱疹、Covid-19 等）
  • 细菌疫苗（脑膜炎双球菌病、肺炎球菌病、百白破、其他）
  • 癌症疫苗
  • 过敏疫苗

按年龄段

  • 儿科
  • 成人

按配销通路

  • 医院和零售药房
  • 政府供应商
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲疫苗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。疫苗市场的主要参与者包括印度血清研究所 Pvt。 Ltd.、Seqirus、赛诺菲、GSK Plc.、默克公司、辉瑞公司、Moderna Inc.、科兴、BioNTech SE、阿斯特捷利康。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：疫苗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 依疾病适应症进行的市场吸引力分析
    • 按年龄组别分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球疫苗市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 次单位疫苗（重组疫苗、结合疫苗、类毒素疫苗）
  • 灭活
  • 活衰减
  • mRNA疫苗
  • 病毒载体疫苗

第 6 章：全球疫苗市场分析：依给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 口服
  • 注射用
  • 鼻腔

第 7 章：全球疫苗市场分析：按疾病适应症

  • 按疾病适应症概述
  • 历史和预测数据
  • 按疾病指征分析
  • 病毒性疾病（肝炎、流感、HPV、MMR、轮状病毒、带状疱疹、Covid-19 等）
  • 细菌疫苗（脑膜炎双球菌病、肺炎球菌病、百白破、其他）
  • 癌症疫苗
  • 过敏疫苗

第 8 章：全球疫苗市场分析：依年龄组别划分

  • 按年龄组别概览
  • 历史和预测数据
  • 按年龄组分析
  • 儿科
  • 成人

第 9 章：全球疫苗市场分析：按分销管道

  • 配销通路概述
  • 历史和预测数据
  • 按配销通路分析
  • 医院和零售药房
  • 政府供应商
  • 其他的

第 10 章：全球疫苗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 11 章：疫苗公司的竞争格局

  • 疫苗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 12 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Serum Institute Of India Pvt. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Seqirus
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GSK Plc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Moderna Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sinovac
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioNTech SE
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AstraZeneca
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11211825

The global demand for Vaccine Market is presumed to reach the market size of nearly USD 159.11 Billion by 2032 from USD 127.41 Billion in 2023 with a CAGR of 2.5% under the study period 2024-2032.

Vaccines are the substance that protects people from diseases by producing immunity to a specific disease. It contains a dead or weakened version of microbes; these microbes stimulate immune system to produce antibodies. Most vaccines are given by injection, nasally, or by mouth. Depending on strategies utilised to activate or stimulate immune system,vaccines are classified into different types:inactivated, attenuated, toxoid, subunit, experimental, valence, heterotypic and conjugate. There are number of the vaccines under development and yet to commercialise.

MARKET DYNAMICS

Global eradication goals and population expansion are predicted to drive the growth of the vaccine market. Annually, an estimated 2-3 million child deaths and 600,000 adult deaths are prevented by vaccination. Still, there are many diseases that claim millions of lives yearly and for which effective vaccines are not yet available this is giving rise to research and development of the new and improved vaccine. High-income countries are major purchasers of vaccine constituting 82% of global vaccine sales. However, vaccine wastage is identified as a major problem to affect market revenue. There is also another concern that some countries have insufficient funds to buy vaccine while some countries don't have resource or mandate required to conduct the vaccine development due to poor functioning national authorities. This affects the future viability of the vaccine. To assess these factors affecting growth, WHO is taking various measures by developing a set of tools to support programmes and partners to measure and address under-vaccination.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vaccine. The growth and trends of Vaccine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines)
  • Inactivated
  • Live Attenuated
  • mRNA vaccines
  • Viral vector vaccines

By Route of Administration

  • Oral
  • Parenteral
  • Nasal

By Disease Indication

  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
  • Cancer Vaccines
  • Allergy Vaccines

By Age Group

  • Pediatric
  • Adult

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine market include Serum Institute Of India Pvt. Ltd., Seqirus, Sanofi, GSK Plc., Merck & Co. Inc., Pfizer Inc., Moderna Inc., Sinovac, BioNTech SE, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VACCINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Disease Indication
    • 3.7.4 Market Attractiveness Analysis By Age Group
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Type
  • 5.4. Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Historic and Forecast Sales By Regions
  • 5.5. Inactivated Historic and Forecast Sales By Regions
  • 5.6. Live Attenuated Historic and Forecast Sales By Regions
  • 5.7. mRNA vaccines Historic and Forecast Sales By Regions
  • 5.8. Viral vector vaccines Historic and Forecast Sales By Regions

6. GLOBAL VACCINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Parenteral Historic and Forecast Sales By Regions
  • 6.6. Nasal Historic and Forecast Sales By Regions

7. GLOBAL VACCINE MARKET ANALYSIS BY DISEASE INDICATION

  • 7.1. Overview By Disease Indication
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Disease Indication
  • 7.4. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
  • 7.5. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
  • 7.6. Cancer Vaccines Historic and Forecast Sales By Regions
  • 7.7. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL VACCINE MARKET ANALYSIS BY AGE GROUP

  • 8.1. Overview By Age Group
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Age Group
  • 8.4. Pediatric Historic and Forecast Sales By Regions
  • 8.5. Adult Historic and Forecast Sales By Regions

9. GLOBAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Distribution Channel
  • 9.4. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Government Suppliers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL VACCINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VACCINE COMPANIES

  • 11.1. Vaccine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF VACCINE INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Serum Institute Of India Pvt. Ltd.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Seqirus
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Sanofi
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. GSK Plc.
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Merck & Co. Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Pfizer Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Moderna Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Sinovac
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. BioNTech SE
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. AstraZeneca
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Vaccine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Vaccine Report
  • Market Research Process
  • Market Research Methodology
  • Global Vaccine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Age Group
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.